0001567619-23-003425.txt : 20230221 0001567619-23-003425.hdr.sgml : 20230221 20230221172706 ACCESSION NUMBER: 0001567619-23-003425 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230216 FILED AS OF DATE: 20230221 DATE AS OF CHANGE: 20230221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Overdorf Michael CENTRAL INDEX KEY: 0001818522 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39402 FILM NUMBER: 23649570 MAIL ADDRESS: STREET 1: C/O ANNEXON, INC. STREET 2: 180 KIMBALL WAY, SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Annexon, Inc. CENTRAL INDEX KEY: 0001528115 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 275414423 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1400 SIERRA POINT PARKWAY STREET 2: BLDG C, SUITE 200 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: (650)-822-5500 MAIL ADDRESS: STREET 1: 1400 SIERRA POINT PARKWAY STREET 2: BLDG C, SUITE 200 CITY: BRISBANE STATE: CA ZIP: 94005 4 1 doc1.xml FORM 4 X0306 4 2023-02-16 0 0001528115 Annexon, Inc. ANNX 0001818522 Overdorf Michael C/O ANNEXON, INC. 1400 SIERRA PT PKWY, BLDG C, 2ND FLOOR BRISBANE CA 94005 0 1 0 0 EVP & Chief Business Officer Common Stock 2023-02-16 4 A 0 18975 0.00 A 46780 D Stock Option (Right to Buy) 5.94 2023-02-16 4 A 0 77050 0 A 2033-02-16 Common Stock 77050 77050 D Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 16 of each year, with the first 1/3rd vesting on February 16, 2024. Includes 36,684 RSUs. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 16, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. /s/ Jennifer Lew, as Attorney-in-Fact for Michael Overdorf 2023-02-21